Antimicrobial Agent Abbreviations
Amp- Ampicilin, Amox/Clav- Amoxicillin/Clavulanate, Amp/Sulb-Ampicillin/Sulbactam, Amik- Amikacin, Aztre-Aztreonam, Cefaz- Cefazolin, Ceftaz-Ceftazidime, Cefep-Cefepime, Chloro-Chloramphenicol, Clinda-Clindamycin, Eryth-Erythromycin, Gent-Gentamicin, Imip-Imipenem, Levo-Levofloxacin,Linz-Linezolid, Mero-Meropenem, Nitro-Nitrofurantoin, Norflox- Norfloxacin, Naf-Nafcillin, Pen-Penicillin, Pip/Tazo-Pipercillin/Tazobactam, Tetra-Tetracycline, Tmp/Sxt- Trimethoprim/Sulfamethoxazole, Tobra-Tobramycin, Vanco-Vancomycin
HUP Outpatients, Jan-Dec 2007, Blood Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Amp/Sulb	Cefaz	Clinda	Eryth	Gent	Naf	Tmp/Sxt	Levo	Tetra	Linz	Vanco
S. aureus	17	0	47	47	59	35	94	47	88	47	94	100	100
Staphylococcus, coag neg	23	17	35	35	35	35	65	35	nt	39	nt	100	100
Enterococcus sp	13	85	nt	nt	nt	23	77(77)*	nt	nt	62	nt	100	77
*hl- high level gentamicin, 500 ug/ml, high level streptomycin, 2000 ug/ml, in parenthesis
**CNS not routinely tested for inducible clinidamycin resistance,  susceptibily may be higher
					Percent Susceptible
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Aztre	Cefaz	Ceftaz	Cefep	Gent	Tobra	Amik	Levo	Pip (Pip/Tazo)	Tmp/Sxt	Mero
E. coli	21	57	76	100	95	100	100	86	95	100	91	86(100)	62	100
E. cloacae	13	0	0	90	0	92	100	100	100	100	92	92(92)	100	100
K. pneumoniae	22	0	82	100	100	100	100	100	100	100	91	0(96)	91	100
HUP Outpatients, Jan-Dec 2007, Non-Urinary Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Amp/Sulb or Amox/Clav	Cefaz	Clinda	Ery	Gent	Naf	Tmp/Sxt	Levo	Tetra	Linz	Vanco
S. aureus	1200	6	52	52	74	36	98	52	96	76	96	100	100
Staphylococcus, coag neg	20	0	50	50	35	35	80	50	nt	40	nt	100	100
Enterococcus sp	68	82	nt	nt	nt	23	nt	nt	nt	67	36	91	88
*CNS not tested for inducible clindamycin resistance, susceptibility may be higher
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Aztr	Cefaz	Ceftaz	Cefep	Gent	Tobra	Amik	Levo	Mero	Pip (Pip/Tazo)	Tmp/Sxt
A. baumannii	13	0	92*	0	0	62	85	86	86	93	92	nt	nt	92
C. koseri	11	0	0	nt	100	100	100	100	100	100	100	100	0	100
Pantoea (Enterobacter) aerogenes	17	0	0	100	0	100	100	100	100	100	100	100	100(100)	100
E. cloacae	32	0	0	93	0	94	97	97	97	100	97	100	94(96)	97
E. coli	81	40	73	100	90	99	99	89	90	100	68	100	59(97)	73
K. pneumoniae	32	0	91	89	94	94	94	100	100	100	94	97	0(94)	88
K. oxytoca	22	0	100	100	86	100	100	100	100	100	100	100	5(100)	100
P. mirabilis	39	100	100	100	100	100	100	100	100	100	95	100	100(100)	95
P. aeruginosa	394	nt	nt	nt	nt	90	83	70	88	77	70	88	91	nt
S. marcescens	45	0	0	0	0	96	96	91	84	96	93	100	96(96)	87
* A. baumannii results are for amp/sulb; amox/clav results can not be inferred from this value
HUP Outpatients, Jan-Dec 2007, Urinary Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Amp/Sulb or Amox/Clav	Cefaz	Ery	Clinda	Gent	Naf	Tmp/Sxt	Levo	Tetra	Linz	Vanco
S. aureus	108	7	78	78	50	55	100	78	98	70	82	100	100
Staphylococcus, coag neg	249	8	40	40	45	45	92	40	nt	67	nt	100	100
Enterococcus sp	409	96	nt	nt	20	nt	nt	nt	nt	85	22	95	97
*hl- high level gentamicin, 500 ug/ml, high level streptomycin, 2000 ug/ml, in parenthesis
**CNS not routinely tested for inducible clindamycin resistance, susceptibility may be higher
					Percent Susceptible
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Gent	Tobra	Levo	Norflox	Nitro	Pip (Pip/Tazo)	Tmp/Sxt	Tetra	Mero
C. koseri	64	0	100	100	100	98	100	100	100	80	nt	98	97	nt
C. freundii	28	0	0	0	79	93	96	93	93	96	nt	93	86	nt
Pantoea (Enterobacter) aerogenes	53	0	0	0	98	100	100	98	98	8	nt	100	100	nt
E. cloacae	41	0	0	0	83	90	85	81	81	22	nt	76	76	nt
E. coli	2818	61	83	93	99	94	95	87	87	97	nt	82	80	nt
K. pneumoniae	395	0	94	92	95	98	95	93	93	30	nt	89	84	nt
K. oxytoca	23	0	83	57	100	100	100	96	96	78	nt	96	100	nt
M. morganii	19	0	0	0	100	90	100	90	95	0	nt	84	68	nt
P. mirabilis	181	96	98	99	100	99	99	96	95	0	nt	95	0	nt
P. aeruginosa	71	nt	nt	nt	94	84	92	60	nt	nt	97	nt	nt	90